The Chemours Company (CC) P/E Ratio History
Deep ValueTrading at -8.5x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2015–2025
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, The Chemours Company (CC) trades at a price-to-earnings ratio of -8.5x, with a stock price of $21.77 and trailing twelve-month earnings per share of $-2.73.
The current P/E is 152% below its 5-year average of 16.4x. Over the past five years, CC's P/E has ranged from a low of 4.4x to a high of 64.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Basic Materials sector median P/E of 23.6x, CC trades at a 136% discount to its sector peers. The sector includes 123 companies with P/E ratios ranging from 1.0x to 184.0x.
Relative to the broader market, CC trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CC P/E vs Peers
Ingredients, pigments and specialty minerals peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $535M | 11.0Lowest | 5.87 | +11% | |
| $8B | 17.7 | 5.50 | -47% | |
| $3B | 42.3 | - | -52% | |
| $14B | 20.2 | 1.12Best | +17% | |
| $4B | 23.6 | 7.59 | +20%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CC Historical P/E Data (2015–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q1 | Mar 31 2025 | $13.53 | $0.21 | 64.5x | +94% |
| FY2024 Q4 | - | $16.90 | $0.58 | 29.3x | -12% |
| FY2024 Q3 | Sep 30 2024 | $20.32 | $0.46 | 44.2x | +33% |
| FY2024 Q2 | Jun 30 2024 | $22.57 | $0.77 | 29.3x | -12% |
| FY2023 Q1 | Mar 31 2023 | $29.94 | $3.09 | 9.7x | -71% |
| FY2022 Q4 | Dec 31 2022 | $30.62 | $3.56 | 8.6x | -74% |
| FY2022 Q3 | Sep 30 2022 | $24.65 | $5.59 | 4.4x | -87% |
| FY2022 Q2 | - | $32.02 | $5.34 | 6.0x | -82% |
| FY2022 Q1 | - | $31.48 | $4.47 | 7.0x | -79% |
| FY2021 Q4 | Dec 31 2021 | $33.56 | $3.61 | 9.3x | -72% |
| FY2021 Q3 | - | $29.06 | $2.35 | 12.4x | -63% |
| FY2021 Q2 | Jun 30 2021 | $34.80 | $1.54 | 22.6x | -32% |
| FY2021 Q1 | Mar 31 2021 | $27.91 | $1.30 | 21.5x | -35% |
| FY2020 Q4 | - | $24.79 | $1.34 | 18.5x | -44% |
| FY2019 Q3 | Sep 30 2019 | $14.94 | $2.43 | 6.1x | -81% |
| FY2019 Q2 | Jun 30 2019 | $24.00 | $3.48 | 6.9x | -79% |
| FY2019 Q1 | Mar 31 2019 | $37.16 | $4.44 | 8.4x | -75% |
| FY2018 Q4 | Dec 31 2018 | $28.22 | $5.47 | 5.2x | -84% |
| FY2018 Q3 | Sep 30 2018 | $39.44 | $5.87 | 6.7x | -80% |
| FY2018 Q2 | Jun 30 2018 | $44.36 | $5.44 | 8.2x | -75% |
| FY2018 Q1 | Mar 31 2018 | $48.71 | $4.75 | 10.3x | -69% |
| FY2017 Q4 | Dec 31 2017 | $50.06 | $3.96 | 12.6x | -62% |
| FY2017 Q3 | Sep 30 2017 | $50.61 | $1.47 | 34.4x | +4% |
| FY2017 Q2 | Jun 30 2017 | $37.92 | $1.50 | 25.3x | -24% |
| FY2017 Q1 | Mar 31 2017 | $38.50 | $0.56 | 68.7x | +107% |
| FY2016 Q4 | Dec 31 2016 | $22.09 | $0.05 | 434.8x | +1209% |
| FY2016 Q3 | Sep 30 2016 | $16.00 | $0.81 | 19.7x | -41% |
| FY2015 Q3 | Sep 30 2015 | $6.47 | $0.42 | 15.4x | -54% |
| FY2015 Q2 | - | $16.00 | $1.17 | 13.7x | -59% |
Average P/E for displayed period: 33.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CC — Frequently Asked Questions
Quick answers to the most common questions about buying CC stock.
What is CC's P/E ratio?
The Chemours Company (CC) trailing twelve-month P/E ratio is -8.5x, based on TTM diluted EPS of $-2.73. The 5-year average P/E is 16.4x and the historical range spans 4.4x to 64.5x.
Is CC stock overvalued or undervalued?
CC trades at -8.5x P/E, below its 5-year average of 16.4x. At the 0th percentile of its historical range (4.4x–64.5x), the stock is priced at a discount to its own history.
Is CC stock expensive?
No, CC is not expensive on a historical basis. The current P/E of -8.5x is below the 5-year average of 16.4x and sits at the 0th percentile of its valuation range.
What is CC's historical P/E range?
Over the past 5 years, CC's P/E ratio has ranged from 4.4x to 64.5x, with a median of 9.3x and an average of 16.4x. The current P/E of -8.5x places the stock at the 0th percentile of this range. Full historical data spans 2015–2025.
How does CC's P/E compare to the S&P 500?
CC trades at -8.5x P/E versus the S&P 500 median of 24.4x. The 135% discount to the market suggests lower growth expectations or perceived higher risk.
How does CC's valuation compare to Basic Materials peers?
The Chemours Company P/E of -8.5x compares to the Basic Materials sector median of 23.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CC's PEG ratio?
CC PEG ratio is N/A, based on a P/E of -8.5x and EPS growth of -549.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CC's earnings yield?
CC earnings yield is N/A, the inverse of its -8.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.